Atrial fibrillation in patients with heart failure

B. John Hynes; Jerry C. Luck; Deborah L. Wolbrette; Luna Bhatta; Mazhar Khan; Soraya Samii; Gerald V. Naccarelli

doi:10.1097/00001573-200301000-00005

Atrial fibrillation in patients with heart failure

B. John Hynes, Jerry C. Luck, Deborah L. Wolbrette, Luna Bhatta, Mazhar Khan, Soraya Samii, Gerald V. Naccarelli

Research output: Contribution to journal › Review article › peer-review

26 Scopus citations

Abstract

Atrial fibrillation and heart failure are very common cardiac disorders, and both are associated with symptoms, significant morbidity, and mortality. Studies have attempted to determine the prognostic significance of atrial fibrillation in patients with heart failure. Whether atrial fibrillation is an independent risk factor of mortality remains controversial. Multiple trials using either pharmacologic or nonpharmacologic therapies in an attempt to manage atrial fibrillation have been developed. The purposes of this review are to present an overview of atrial fibrillation in patients with heart failure and to discuss the prevalence, prognostic significance, complications, mechanisms, and trials that have formed the therapies presently used.

Original language	English (US)
Pages (from-to)	32-38
Number of pages	7
Journal	Current Opinion in Cardiology
Volume	18
Issue number	1
DOIs	https://doi.org/10.1097/00001573-200301000-00005
State	Published - Jan 2003

All Science Journal Classification (ASJC) codes

Cardiology and Cardiovascular Medicine

Access to Document

10.1097/00001573-200301000-00005

Cite this

@article{eab272c0d94e4646a7815df68ee61af5,

title = "Atrial fibrillation in patients with heart failure",

abstract = "Atrial fibrillation and heart failure are very common cardiac disorders, and both are associated with symptoms, significant morbidity, and mortality. Studies have attempted to determine the prognostic significance of atrial fibrillation in patients with heart failure. Whether atrial fibrillation is an independent risk factor of mortality remains controversial. Multiple trials using either pharmacologic or nonpharmacologic therapies in an attempt to manage atrial fibrillation have been developed. The purposes of this review are to present an overview of atrial fibrillation in patients with heart failure and to discuss the prevalence, prognostic significance, complications, mechanisms, and trials that have formed the therapies presently used.",

author = "Hynes, {B. John} and Luck, {Jerry C.} and Wolbrette, {Deborah L.} and Luna Bhatta and Mazhar Khan and Soraya Samii and Naccarelli, {Gerald V.}",

year = "2003",

month = jan,

doi = "10.1097/00001573-200301000-00005",

language = "English (US)",

volume = "18",

pages = "32--38",

journal = "Current Opinion in Cardiology",

issn = "0268-4705",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Atrial fibrillation in patients with heart failure

AU - Hynes, B. John

AU - Luck, Jerry C.

AU - Wolbrette, Deborah L.

AU - Bhatta, Luna

AU - Khan, Mazhar

AU - Samii, Soraya

AU - Naccarelli, Gerald V.

PY - 2003/1

Y1 - 2003/1

N2 - Atrial fibrillation and heart failure are very common cardiac disorders, and both are associated with symptoms, significant morbidity, and mortality. Studies have attempted to determine the prognostic significance of atrial fibrillation in patients with heart failure. Whether atrial fibrillation is an independent risk factor of mortality remains controversial. Multiple trials using either pharmacologic or nonpharmacologic therapies in an attempt to manage atrial fibrillation have been developed. The purposes of this review are to present an overview of atrial fibrillation in patients with heart failure and to discuss the prevalence, prognostic significance, complications, mechanisms, and trials that have formed the therapies presently used.

AB - Atrial fibrillation and heart failure are very common cardiac disorders, and both are associated with symptoms, significant morbidity, and mortality. Studies have attempted to determine the prognostic significance of atrial fibrillation in patients with heart failure. Whether atrial fibrillation is an independent risk factor of mortality remains controversial. Multiple trials using either pharmacologic or nonpharmacologic therapies in an attempt to manage atrial fibrillation have been developed. The purposes of this review are to present an overview of atrial fibrillation in patients with heart failure and to discuss the prevalence, prognostic significance, complications, mechanisms, and trials that have formed the therapies presently used.

UR - http://www.scopus.com/inward/record.url?scp=0037233251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037233251&partnerID=8YFLogxK

U2 - 10.1097/00001573-200301000-00005

DO - 10.1097/00001573-200301000-00005

M3 - Review article

C2 - 12496499

AN - SCOPUS:0037233251

SN - 0268-4705

VL - 18

SP - 32

EP - 38

JO - Current Opinion in Cardiology

JF - Current Opinion in Cardiology

IS - 1

ER -

Atrial fibrillation in patients with heart failure

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this